Loading insider details...
Beta
Latest Form 4 (Sep 28, 2026): Disposition to Issuer of 9,160 ASND shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 28, 2026 | Ascendis Pharma A/S (ASND) | Disposition to Issuer | 9,160 | n/a |
| Aug 19, 2026 | Keros Therapeutics, Inc. (KROS) | Purchase | 1,000 | $10.3K |
| Aug 19, 2026 | Ascendis Pharma A/S (ASND) | Purchase | 1,100 | $270.4K |
| Jul 17, 2026 | Keros Therapeutics, Inc. (KROS) | Purchase | 1,000 | $10.6K |
| Jun 17, 2026 | Keros Therapeutics, Inc. (KROS) | Purchase | 1,000 | $10.2K |
| Jun 12, 2026 | Immunome Inc. (IMNM) | Grant/Award | 9,897 | n/a |
| Jun 10, 2026 | INCYTE CORP (INCY) | Grant/Award | 1,642 | n/a |
| Jun 9, 2026 | Immunome Inc. (IMNM) | Sale | 500 | $9.7K |
| Jun 5, 2026 | Keros Therapeutics, Inc. (KROS) | Grant/Award | 7,142 | n/a |
| Jun 1, 2026 | Ascendis Pharma A/S (ASND) | Purchase | 200 | $44.8K |